Q32 Bio Inc. (QTTB)

NASDAQ: QTTB · USD

$9.09

+0.38 (+4.4%)· Recorded snapshot

Market cap	270.6M
Revenue (ttm)	53.7M
Net income (ttm)	33.8M
EPS (ttm)	$2.27
Shares out	29.8M
P/E (trailing)	4.0x
Volume	384,154
Beta	-0.11

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 53.7M
Net income (ttm): 33.8M
EPS (ttm): $2.27
P/E (trailing): 4.0x
Market cap: 270.6M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Halten

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/E4

P25 n/aP50 n/aP75 n/a

ROE72.1

P25 n/aP50 n/aP75 n/a

ROIC22.8

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All QTTB indicators

Market & fundamental data

Available fields

194

Groups with data

Currency

USD

Showing 194 of 194 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001661998
Company name	Q32 Bio Inc.
Country	United States
Country code	US
CUSIP number	746964105
Earnings date	2026-11-12
Earnings time	bmo
Employees	22
Employees change	-7
Employees growth	-24.14%
Enterprise value	$169.6M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2015
Industry	Biotechnology
Is primary listing	Yes
Is SPAC	No
ISIN number	US7469641051
Last 10-K release date	2026-03-10
Last earnings date	2026-08-05
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$270.6M
Market cap category	Micro-Cap
Next earnings date	2026-11-12
Options	Yes
Price	$9.09
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	QTTB
U.S. state	Massachusetts
Website	https://www.q32bio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	25%
EV/Earnings	4.88x
EV/EBIT	7.67x
EV/EBITDA	7.55x
EV/Sales	3.07x
FCF / EV yield	-12.04%
FCF yield	-7.46%
Forward EV/Sales	494.16x
Forward P/S	797.09x
Graham number	15.10257
Graham upside	69.22%
P/B ratio	1.95x
P/E ratio	4x
P/S ratio	4.94x
Price / tangible book value	2.51x
Price/EBITDA ratio	12.18x
Sector forward P/E	23.56x
Sector P/E	50.08x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	39.94%
EBITDA margin	40.6%
Gross margin	73.3%
Operating margin	39.94%
Pretax margin	62.87%
Profit margin	62.87%
Profit per employee	$1.5M
Profitable years	1
Revenue per employee	$2.4M
ROA	14.74%
ROCE	19.43%
ROE	72.14%
ROIC	22.8%
SBC / revenue	10.94%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	10
EPS growth years	2
Net income growth quarters	5
Net income growth years	2
Revenue growth 3Y	100.66%
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Depreciation and amortization	$356,000
EBIT	$21.5M
EBITDA	$21.8M
EPS	$2.27
FCF per share	$-0.67
Financing cash flow	$64.3M
Free cash flow	$-19.8M
Free cash flow minus SBC	$-25.7M
Gross profit	$39.4M
Investing cash flow	$7M
Net borrowing	$-12.9M
Net cash flow	$51.4M
Net income	$33.8M
Operating cash flow minus SBC	$-25.7M
Operating income	$21.5M
Revenue	$53.7M
Stock-based compensation	$5.9M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	3.36
Book value per share	$4.46
Debt / EBITDA	0.23
Debt / equity	0.05
Interest coverage	23.85
Long-term assets	$6.2M
Long-term liabilities	$4.6M
Net cash (debt)	$101M
Net cash / market cap	38%
Net cash growth	179.44%
Net debt / EBITDA	-4.63
Net debt / equity	-0.95
Piotroski F-Score	3
Property, plant and equipment	$5.6M
Shareholders' equity	$105.9M
Tangible book value	$105.9M
Tangible book value per share	$4.46
Total assets	$115.9M
Total cash	$106.3M
Total debt	$5.3M
Total liabilities	$10M
WACC	3.84%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.59
Current assets	$109.6M
Current liabilities	$5.4M
Current ratio	20.3
Net working capital	$-1.3M
Quick ratio	19.78
Working capital	$104.2M
Working capital turnover	0.71

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-21.91%
Dividend yield	0%
Shareholder yield	-21.91%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$10.65
1D price change	4.36%
1M price change	3.08%
1M total return	3.08%
1W price change	4.87%
1W total return	4.87%
1Y price change	222.86%
1Y return CAGR	223.12%
1Y total return	222.86%
20-day SMA	$8.31
200-day SMA	$9.18
3M price change	-40.57%
3M total return	-40.57%
50-day SMA	$10.73
50-day SMA vs 200-day SMA	50over200
52-week high	$23.57
52-week high date	2026-07-14
52-week low	$1.91
52-week low date	2025-11-20
6M price change	65.27%
6M total return	65.27%
All-time high	$53.79
All-time high date	2024-09-11
All-time low	$1.35
All-time low date	2025-07-07
Average true range (ATR)	$0.63
Average volume	825.4K
Beta (1Y)	-0.47
Beta (2Y)	0.23
Beta (5Y)	-0.11
Change from 52-week high	-61.43%
Change from 52-week low	377.17%
Change from all-time high	-83.19%
Change from all-time low	572.12%
Change from open	2.94%
Day's gap	1.38%
Dollar volume	$3.5M
High price	$9.09
Low price	$8.82
Monthly RSI	49.16
Open price	$8.83
Position in 52-week range	100%
Premarket change	-1.15%
Premarket close	$8.71
Premarket price	$8.61
Previous close	$8.71
Price vs 150-day SMA	-15.12%
Price vs 20-day SMA	8.77%
Price vs 200-day SMA	-1.55%
Price vs 50-day SMA	-15.71%
Relative volume	0.47
RSI	49.64
Sharpe ratio	1.32
Sortino ratio	3.41
Volume	384.2K
Weekly RSI	46.81
YTD price change	172.29%
YTD total return	172.29%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	12.7M
Float percentage	42.73%
Shares change (QoQ)	44.32%
Shares change (YoY)	21.91%
Shares held by insiders	0.76%
Shares held by institutions	28.2%
Shares outstanding	29.8M
Short % of float	36.73%
Short % of shares	15.69%
Short ratio	5.1 days

Deeper analysis on QTTB

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this QTTB report

Is a complete QTTB research report available?

No complete published report is available for Q32 Bio Inc. (QTTB) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Q32 Bio Inc. (QTTB)

Price

Financial snapshot

Fair-value bridge

Latest news · QTTB

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All QTTB indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on QTTB

Frequently asked questions